{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T03:32:46Z","timestamp":1783567966908,"version":"3.55.0"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Young Talents&amp;#x2019; Science and Technology Innovation Project of Hainan Association for Science and Technology"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The zoonotic enterohaemorrhagic <jats:italic>Escherichia coli<\/jats:italic> (EHEC) O157:H7 can disrupt intestinal epithelial barrier function and in turn leading to serious intestinal and systemic disease. PR39 could effectively inhibit the growth of Gram-negative bacteria, but there is little knowledge of its effects on intestinal barrier function and the microbiota in <jats:italic>E<\/jats:italic>. <jats:italic>coli<\/jats:italic>-challenged mice. In this study, an intestinal disease caused by EHEC O157:H7 was established, to analyze the effect of PR39 on EHEC O157:H7 induced intestinal epithelial barrier injury and disorder. Interestingly, PR39 attenuated EHEC O157:H7-induced systemic symptoms and significantly decreased mortality and the degree of <jats:italic>E<\/jats:italic>. <jats:italic>coli<\/jats:italic> shedding in faeces. Furthermore, the infiltration index of macrophages and neutrophils in intestine of the PR39 treatment group were obviously attenuated, along with the level of apoptosis. PR39 treatment group had distinctly improved tight junction associated proteins\u2019 expression after EHEC O157:H7 caused injury. Additionally, the sequencing analysis of cecum microbiota showed that PR39 altered the abnormal increase in <jats:italic>Bacteroides<\/jats:italic> caused by EHEC O157:H7 and promoted the growth of probiotics such as <jats:italic>Lactobacillus<\/jats:italic>. In conclusion, cathelicidin-derived PR39 could effectively improve EHEC O157:H7-induced epithelial barrier injury, and dysfunction of immune and microbiota homeostasis in the intestinal tract, indicating that PR39 could be an excellent potential drug for zoonotic EHEC O157:H7-related intestinal disease.<\/jats:p>","DOI":"10.1038\/s41598-019-45913-6","type":"journal-article","created":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T10:03:09Z","timestamp":1561975389000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Cathelicidin- derived PR39 protects enterohemorrhagic Escherichia coli O157:H7 challenged mice by improving epithelial function and balancing the microbiota in the intestine"],"prefix":"10.1038","volume":"9","author":[{"given":"Zhang","family":"Haiwen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Rui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhang","family":"Bingxi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guan","family":"Qingfeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Beibei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeng","family":"Jifeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Xuemei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Kebang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,1]]},"reference":[{"key":"45913_CR1","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.ijmm.2005.06.009","volume":"295","author":"H Karch","year":"2005","unstructured":"Karch, H., Tarr, P. I. & Bielaszewska, M. Enterohaemorrhagic Escherichia coli in human medicine. Int J Med Microbiol. 295, 405\u2013418 (2005).","journal-title":"Int J Med Microbiol."},{"key":"45913_CR2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1016\/S0140-6736(10)60963-4","volume":"376","author":"H Pennington","year":"2010","unstructured":"Pennington, H. Escherichia coli O157. Lancet. 376, 1428\u20131435 (2010).","journal-title":"Lancet."},{"key":"45913_CR3","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.patbio.2015.03.001","volume":"63","author":"C Picard","year":"2015","unstructured":"Picard, C. et al. Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome. Pathol Biol (Paris). 63, 136\u2013143 (2015).","journal-title":"Pathol Biol (Paris)."},{"key":"45913_CR4","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1086\/517438","volume":"177","author":"P Feng","year":"1998","unstructured":"Feng, P., Lampel, K. A., Karch, H. & Whittam, T. S. Genotypic and phenotypic changes in the emergence of Escherichia coli O157:H7. J Infect Dis. 177, 1750\u20131753 (1998).","journal-title":"J Infect Dis."},{"key":"45913_CR5","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1093\/jac\/dkv162","volume":"70","author":"M Agger","year":"2015","unstructured":"Agger, M., Scheutz, F., Villumsen, S., Molbak, K. & Petersen, A. M. Antibiotic treatment of verocytotoxin-producing Escherichia coli (VTEC) infection: a systematic review and a proposal. J Antimicrob Chemother. 70, 2440\u20132446 (2015).","journal-title":"J Antimicrob Chemother."},{"key":"45913_CR6","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.vetmic.2009.04.011","volume":"140","author":"MA Karmali","year":"2010","unstructured":"Karmali, M. A., Gannon, V. & Sargeant, J. M. Verocytotoxin-producing Escherichia coli (VTEC). Vet Microbiol. 140, 360\u2013370 (2010).","journal-title":"Vet Microbiol."},{"key":"45913_CR7","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3109\/07388551.2011.594423","volume":"32","author":"M Pasupuleti","year":"2012","unstructured":"Pasupuleti, M., Schmidtchen, A. & Malmsten, M. Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol. 32, 143\u2013171 (2012).","journal-title":"Crit Rev Biotechnol."},{"key":"45913_CR8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/415389a","volume":"415","author":"M Zasloff","year":"2002","unstructured":"Zasloff, M. Antimicrobial peptides of multicellular organisms. Nature. 415, 389\u2013395 (2002).","journal-title":"Nature."},{"key":"45913_CR9","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/35106587","volume":"414","author":"V Nizet","year":"2001","unstructured":"Nizet, V. et al. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature. 414, 454\u2013457 (2001).","journal-title":"Nature."},{"key":"45913_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1038\/nm1407","volume":"12","author":"M Chromek","year":"2006","unstructured":"Chromek, M. et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med. 12, 636\u2013641 (2006).","journal-title":"Nat Med."},{"key":"45913_CR11","doi-asserted-by":"publisher","first-page":"4901","DOI":"10.4049\/jimmunol.174.8.4901","volume":"174","author":"M Iimura","year":"2005","unstructured":"Iimura, M. et al. Cathelicidin mediates innate intestinal defense against colonization with epithelial adherent bacterial pathogens. J Immunol. 174, 4901\u20134907 (2005).","journal-title":"J Immunol."},{"key":"45913_CR12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/j.1432-1033.1991.tb16442.x","volume":"202","author":"B Agerberth","year":"1991","unstructured":"Agerberth, B. et al. Amino acid sequence of PR-39. Isolation from pig intestine of a new member of the family of proline-arginine-rich antibacterial peptides. Eur J Biochem. 202, 849\u2013854 (1991).","journal-title":"Eur J Biochem."},{"key":"45913_CR13","doi-asserted-by":"publisher","first-page":"e95939","DOI":"10.1371\/journal.pone.0095939","volume":"9","author":"EJ Veldhuizen","year":"2014","unstructured":"Veldhuizen, E. J. et al. Antimicrobial and immunomodulatory activities of PR-39 derived peptides. PLoS One. 9, e95939 (2014).","journal-title":"PLoS One."},{"key":"45913_CR14","doi-asserted-by":"publisher","first-page":"2817","DOI":"10.1002\/eji.201142055","volume":"41","author":"K Wuerth","year":"2011","unstructured":"Wuerth, K. & Hancock, R. E. New insights into cathelicidin modulation of adaptive immunity. Eur J Immunol. 41, 2817\u20132819 (2011).","journal-title":"Eur J Immunol."},{"key":"45913_CR15","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/S0925-4439(02)00170-9","volume":"1588","author":"M Madhani","year":"2002","unstructured":"Madhani, M. et al. Antibacterial peptide PR-39 affects local nitric oxide and preserves tissue oxygenation in the liver during septic shock. Biochim Biophys Acta. 1588, 232\u2013240 (2002).","journal-title":"Biochim Biophys Acta."},{"key":"45913_CR16","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.vetimm.2014.05.012","volume":"160","author":"Y Gao","year":"2014","unstructured":"Gao, Y. et al. Expression pattern of porcine antimicrobial peptide PR-39 and its induction by enterotoxigenic Escherichia coli (ETEC) F4ac. Vet Immunol Immunopathol. 160, 260\u2013265 (2014).","journal-title":"Vet Immunol Immunopathol."},{"key":"45913_CR17","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1111\/j.1532-5415.2006.00682.x","volume":"54","author":"G Reiss","year":"2006","unstructured":"Reiss, G., Kunz, P., Koin, D. & Keeffe, E. B. Escherichia coli O157:H7 infection in nursing homes: review of literature and report of recent outbreak. J Am Geriatr Soc. 54, 680\u2013684 (2006).","journal-title":"J Am Geriatr Soc."},{"key":"45913_CR18","doi-asserted-by":"publisher","first-page":"5309","DOI":"10.3390\/nu7075218","volume":"7","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Xu, A., Liu, P. & Li, Z. Effects of Fuzhuan Brick-Tea Water Extract on Mice Infected with E. coli O157:H7. Nutrients. 7, 5309\u20135326 (2015).","journal-title":"Nutrients."},{"key":"45913_CR19","doi-asserted-by":"publisher","first-page":"7839","DOI":"10.1073\/pnas.87.20.7839","volume":"87","author":"AE Jerse","year":"1990","unstructured":"Jerse, A. E., Yu, J., Tall, B. D. & Kaper, J. B. A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells. Proc Natl Acad Sci USA 87, 7839\u20137843 (1990).","journal-title":"Proc Natl Acad Sci USA"},{"key":"45913_CR20","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.lfs.2016.03.041","volume":"152","author":"F Han","year":"2016","unstructured":"Han, F. et al. Cathelicidin-BF ameliorates lipopolysaccharide-induced intestinal epithelial barrier disruption in rat. Life Sci. 152, 199\u2013209 (2016).","journal-title":"Life Sci."},{"key":"45913_CR21","first-page":"383","volume":"71","author":"RJ Fernandez-Brando","year":"2011","unstructured":"Fernandez-Brando, R. J. et al. Update on the treatment of endemic hemolytic uremic syndrome. Pathogenesis and treatment of the most severe systemic complication of infections by Shiga toxin-producing Escherichia coli. Medicina (B Aires). 71, 383\u2013389 (2011).","journal-title":"Medicina (B Aires)."},{"key":"45913_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3945\/an.115.010405","volume":"7","author":"AM Meyer","year":"2016","unstructured":"Meyer, A. M. & Caton, J. S. Role of the Small Intestine in Developmental Programming: Impact of Maternal Nutrition on the Dam and Offspring. Adv Nutr. 7, 169\u2013178 (2016).","journal-title":"Adv Nutr."},{"key":"45913_CR23","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3390\/nu7010572","volume":"7","author":"GL Gopalsamy","year":"2015","unstructured":"Gopalsamy, G. L. et al. The relevance of the colon to zinc nutrition. Nutrients. 7, 572\u2013583 (2015).","journal-title":"Nutrients."},{"key":"45913_CR24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1177\/0300985817691582","volume":"54","author":"KA Eaton","year":"2017","unstructured":"Eaton, K. A., Fontaine, C., Friedman, D. I., Conti, N. & Alteri, C. J. Pathogenesis of Colitis in Germ-Free Mice Infected With EHEC O157:H7. Vet Pathol. 54, 710\u2013719 (2017).","journal-title":"Vet Pathol."},{"key":"45913_CR25","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1016\/j.vaccine.2018.02.060","volume":"36","author":"A Albanese","year":"2018","unstructured":"Albanese, A. et al. Immunization of pregnant cows with Shiga toxin-2 induces high levels of specific colostral antibodies and lactoferrin able to neutralize E. coli O157:H7 pathogenicity. Vaccine. 36, 1728\u20131735 (2018).","journal-title":"Vaccine."},{"key":"45913_CR26","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/abbs\/gmw061","volume":"48","author":"J Liu","year":"2016","unstructured":"Liu, J. et al. Cathelicidin PR-39 peptide inhibits hypoxia\/reperfusion-induced kidney cell apoptosis by suppression of the endoplasmic reticulum-stress pathway. Acta Biochim Biophys Sin (Shanghai). 48, 714\u2013722 (2016).","journal-title":"Acta Biochim Biophys Sin (Shanghai)."},{"key":"45913_CR27","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1111\/j.1747-0285.2007.00540.x","volume":"70","author":"CR Ross","year":"2007","unstructured":"Ross, C. R., Ricevuti, G. & Scovassi, A. I. The antimicrobial peptide PR-39 has a protective effect against HeLa cell apoptosis. Chem Biol Drug Des. 70, 154\u2013157 (2007).","journal-title":"Chem Biol Drug Des."},{"key":"45913_CR28","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0145-305X(03)00135-6","volume":"28","author":"B Ramanathan","year":"2004","unstructured":"Ramanathan, B., Wu, H., Ross, C. R. & Blecha, F. PR-39, a porcine antimicrobial peptide, inhibits apoptosis: involvement of caspase-3. Dev Comp Immunol. 28, 163\u2013169 (2004).","journal-title":"Dev Comp Immunol."},{"key":"45913_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1097\/MPG.0b013e3181ae2ba0","volume":"50","author":"EJ Park","year":"2010","unstructured":"Park, E. J., Thomson, A. B. & Clandinin, M. T. Protection of intestinal occludin tight junction protein by dietary gangliosides in lipopolysaccharide-induced acute inflammation. J Pediatr Gastroenterol Nutr. 50, 321\u2013328 (2010).","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"45913_CR30","doi-asserted-by":"publisher","first-page":"e12220","DOI":"10.1371\/journal.pone.0012220","volume":"5","author":"M Chichlowski","year":"2010","unstructured":"Chichlowski, M., Westwood, G. S., Abraham, S. N. & Hale, L. P. Role of mast cells in inflammatory bowel disease and inflammation-associated colorectal neoplasia in IL-10-deficient mice. PLoS One. 5, e12220, https:\/\/doi.org\/10.1371\/journal.pone.0012220 (2010).","journal-title":"PLoS One."},{"key":"45913_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.taap.2009.08.002","volume":"241","author":"IC McCall","year":"2009","unstructured":"McCall, I. C. et al. Effects of phenol on barrier function of a human intestinal epithelial cell line correlate with altered tight junction protein localization. Toxicol Appl Pharmacol. 241, 61\u201370 (2009).","journal-title":"Toxicol Appl Pharmacol."},{"key":"45913_CR32","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-2180-9-63","volume":"9","author":"H Qin","year":"2009","unstructured":"Qin, H., Zhang, Z., Hang, X. & Jiang, Y. L. Plantarum prevents enteroinvasive Escherichia coli-induced tight junction proteins changes in intestinal epithelial cells. BMC Microbiol. 9, 63 (2009).","journal-title":"BMC Microbiol."},{"key":"45913_CR33","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.4049\/jimmunol.1402300","volume":"194","author":"F Han","year":"2015","unstructured":"Han, F. et al. Porcine beta-defensin 2 attenuates inflammation and mucosal lesions in dextran sodium sulfate-induced colitis. J Immunol. 194, 1882\u20131893 (2015).","journal-title":"J Immunol."},{"key":"45913_CR34","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/labinvest.2010.91","volume":"90","author":"JL Roxas","year":"2010","unstructured":"Roxas, J. L. et al. Enterohemorrhagic E. coli alters murine intestinal epithelial tight junction protein expression and barrier function in a Shiga toxin independent manner. Lab Invest. 90, 1152\u20131168 (2010).","journal-title":"Lab Invest."},{"key":"45913_CR35","first-page":"182","volume":"334","author":"ME Johansson","year":"2011","unstructured":"Johansson, M. E. & Hansson, G. C. Microbiology. Keeping bacteria at a distance. Science. 334, 182\u2013183 (2011).","journal-title":"Keeping bacteria at a distance. Science."},{"key":"45913_CR36","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1136\/gut.47.4.589","volume":"47","author":"AP Corfield","year":"2000","unstructured":"Corfield, A. P. et al. Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease. Gut. 47, 589\u2013594 (2000).","journal-title":"Gut."},{"key":"45913_CR37","doi-asserted-by":"publisher","first-page":"536S","DOI":"10.1042\/bst023536s","volume":"23","author":"N Myerscough","year":"1995","unstructured":"Myerscough, N., Warren, B., Gough, M. & Corfield, A. Expression of mucin genes in ulcerative colitis. Biochem Soc Trans. 23, 536S (1995).","journal-title":"Biochem Soc Trans."},{"key":"45913_CR38","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1023\/A:1024175629909","volume":"48","author":"M Faure","year":"2003","unstructured":"Faure, M. et al. Mucin production and composition is altered in dextran sulfate sodium-induced colitis in rats. Dig Dis Sci. 48, 1366\u20131373 (2003).","journal-title":"Dig Dis Sci."},{"key":"45913_CR39","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.4049\/jimmunol.1601221","volume":"198","author":"H Yi","year":"2017","unstructured":"Yi, H., Hu, W., Chen, S., Lu, Z. & Wang, Y. Cathelicidin-WA Improves Intestinal Epithelial Barrier Function and Enhances Host Defense against Enterohemorrhagic Escherichia coli O157:H7 Infection. J Immunol. 198, 1696\u20131705 (2017).","journal-title":"J Immunol."},{"key":"45913_CR40","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jnutbio.2011.01.007","volume":"23","author":"EL Vieira","year":"2012","unstructured":"Vieira, E. L. et al. Oral administration of sodium butyrate attenuates inflammation and mucosal lesion in experimental acute ulcerative colitis. J Nutr Biochem. 23, 430\u2013436 (2012).","journal-title":"J Nutr Biochem."},{"key":"45913_CR41","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1016\/j.peptides.2008.07.013","volume":"29","author":"E Talero","year":"2008","unstructured":"Talero, E. et al. Acute and chronic responses associated with adrenomedullin administration in experimental colitis. Peptides. 29, 2001\u20132012 (2008).","journal-title":"Peptides."},{"key":"45913_CR42","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1023\/A:1011975218006","volume":"46","author":"S Choudhary","year":"2001","unstructured":"Choudhary, S. et al. Novel antioxidants zolimid and AEOL11201 ameliorate colitis in rats. Dig Dis Sci. 46, 2222\u20132230 (2001).","journal-title":"Dig Dis Sci."},{"key":"45913_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ejphar.2006.09.066","volume":"554","author":"HH Hagar","year":"2007","unstructured":"Hagar, H. H., El-Medany, A., El-Eter, E. & Arafa, M. Ameliorative effect of pyrrolidinedithiocarbamate on acetic acid-induced colitis in rats. Eur J Pharmacol. 554, 69\u201377 (2007).","journal-title":"Eur J Pharmacol."},{"key":"45913_CR44","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/j.1572-0241.2000.02194.x","volume":"95","author":"JL Goldstein","year":"2000","unstructured":"Goldstein, J. L. et al. Reduced risk of upper gastrointestinal ulcer complications with celecoxib, a novel COX-2 inhibitor. Am J Gastroenterol. 95, 1681\u20131690 (2000).","journal-title":"Am J Gastroenterol."},{"key":"45913_CR45","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.gtc.2006.07.002","volume":"35","author":"SH Itzkowitz","year":"2006","unstructured":"Itzkowitz, S. H. Molecular biology of dysplasia and cancer in inflammatory bowel disease. Gastroenterol Clin North Am. 35, 553\u2013571 (2006).","journal-title":"Gastroenterol Clin North Am."},{"key":"45913_CR46","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cimid.2016.10.004","volume":"49","author":"R Holani","year":"2016","unstructured":"Holani, R. et al. Proline-arginine rich (PR-39) cathelicidin: Structure, expression and functional implication in intestinal health. Comp Immunol Microbiol Infect Dis. 49, 95\u2013101 (2016).","journal-title":"Comp Immunol Microbiol Infect Dis."},{"key":"45913_CR47","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1017\/S0007114507691910","volume":"97","author":"T Thymann","year":"2007","unstructured":"Thymann, T. et al. Antimicrobial treatment reduces intestinal microflora and improves protein digestive capacity without changes in villous structure in weanling pigs. Br J Nutr. 97, 1128\u20131137 (2007).","journal-title":"Br J Nutr."},{"key":"45913_CR48","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1292\/jvms.17-0485","volume":"80","author":"S Kishida","year":"2018","unstructured":"Kishida, S., Kato-Mori, Y. & Hagiwara, K. Influence of changes in the intestinal microflora on the immune function in mice. J Vet Med Sci. 80, 440\u2013446 (2018).","journal-title":"J Vet Med Sci."},{"key":"45913_CR49","unstructured":"Shcherbakova, P. L. et al. Lactase deficiency in patients with postinfectious irritable bowel syndrome and the role of intestinal microflora in its development. Eksp Klin Gastroenterol. 91\u201398 (2012)."},{"key":"45913_CR50","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1093\/ps\/85.6.974","volume":"85","author":"WA Awad","year":"2006","unstructured":"Awad, W. A., Bohm, J., Razzazi-Fazeli, E., Ghareeb, K. & Zentek, J. Effect of addition of a probiotic microorganism to broiler diets contaminated with deoxynivalenol on performance and histological alterations of intestinal villi of broiler chickens. Poult Sci. 85, 974\u2013979 (2006).","journal-title":"Poult Sci."},{"key":"45913_CR51","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.1021\/acs.jafc.9b00861","volume":"67","author":"H Zhang","year":"2019","unstructured":"Zhang, H. et al. Oral Administration of Bovine Lactoferrin-Derived Lactoferricin(Lfcin) B Could Attenuate Enterohemorrhagic Escherichia coli O157:H7 Induced Intestinal Disease through Improving Intestinal Barrier Function and Microbiota. J. Agric. Food Chem. 67, 3932\u20133945 (2019).","journal-title":"J. Agric. Food Chem."},{"key":"45913_CR52","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1136\/gut.52.7.988","volume":"52","author":"S Resta-Lenert","year":"2003","unstructured":"Resta-Lenert, S. & Barrett, K. E. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut. 52, 988\u2013997 (2003).","journal-title":"Gut."},{"key":"45913_CR53","doi-asserted-by":"publisher","first-page":"2517","DOI":"10.2527\/jas.2006-237","volume":"85","author":"DM Albin","year":"2007","unstructured":"Albin, D. M., Wubben, J. E., Rowlett, J. M., Tappenden, K. A. & Nowak, R. A. Changes in small intestinal nutrient transport and barrier function after lipopolysaccharide exposure in two pig breeds. J Anim Sci. 85, 2517\u20132523 (2007).","journal-title":"J Anim Sci."},{"key":"45913_CR54","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1021\/acs.molpharmaceut.5b00069","volume":"12","author":"H Zhang","year":"2015","unstructured":"Zhang, H. et al. Cathelicidin-BF, a novel antimicrobial peptide from Bungarus fasciatus, attenuates disease in a dextran sulfate sodium model of colitis. Mol Pharm. 12, 1648\u20131661 (2015).","journal-title":"Mol Pharm."},{"key":"45913_CR55","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat Methods. 7, 335\u2013336 (2010).","journal-title":"Nat Methods."},{"key":"45913_CR56","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","volume":"41","author":"C Quast","year":"2013","unstructured":"Quast, C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590\u2013596 (2013).","journal-title":"Nucleic Acids Res."},{"key":"45913_CR57","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1128\/AEM.03006-05","volume":"72","author":"TZ DeSantis","year":"2006","unstructured":"DeSantis, T. Z. et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl Environ Microbiol. 72, 5069\u20135072 (2006).","journal-title":"Appl Environ Microbiol."},{"key":"45913_CR58","doi-asserted-by":"publisher","first-page":"D141","DOI":"10.1093\/nar\/gkn879","volume":"37","author":"JR Cole","year":"2009","unstructured":"Cole, J. R. et al. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 37, D141\u2013145 (2009).","journal-title":"Nucleic Acids Res."},{"key":"45913_CR59","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).","journal-title":"Genome Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45913-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45913-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45913-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:00:44Z","timestamp":1671274844000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45913-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,1]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["45913"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-45913-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,1]]},"assertion":[{"value":"5 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9456"}}